632 related articles for article (PubMed ID: 32179573)
21. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
22. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
23. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
Murphy LL; Steger RW; Smith MS; Bartke A
Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
[TBL] [Abstract][Full Text] [Related]
24. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Jamontt JM; Molleman A; Pertwee RG; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):712-23. PubMed ID: 20590574
[TBL] [Abstract][Full Text] [Related]
25. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
Hiltunen AJ; Järbe TU
Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
[TBL] [Abstract][Full Text] [Related]
26. Effect of cannabidiolic acid and ∆
Rock EM; Limebeer CL; Parker LA
Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659
[TBL] [Abstract][Full Text] [Related]
27. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
[TBL] [Abstract][Full Text] [Related]
28. Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors.
Barnes RC; Banjara S; McHann MC; Almodovar S; Henderson-Redmond AN; Morgan DJ; Castro-Piedras I; Guindon J
J Pharmacol Exp Ther; 2024 Jan; 388(2):655-669. PubMed ID: 38129125
[TBL] [Abstract][Full Text] [Related]
29. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
Wakley AA; Wiley JL; Craft RM
Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
[TBL] [Abstract][Full Text] [Related]
30. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
[TBL] [Abstract][Full Text] [Related]
31. Antinociception produced by nonsteroidal anti-inflammatory drugs in female vs male rats.
Craft RM; Hewitt KA; Britch SC
Behav Pharmacol; 2021 Apr; 32(2&3):153-169. PubMed ID: 33290343
[TBL] [Abstract][Full Text] [Related]
32. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
[TBL] [Abstract][Full Text] [Related]
34. Effects of daily Δ
Withey SL; Kangas BD; Charles S; Gumbert AB; Eisold JE; George SR; Bergman J; Madras BK
Drug Alcohol Depend; 2021 Apr; 221():108629. PubMed ID: 33640678
[TBL] [Abstract][Full Text] [Related]
35. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
[TBL] [Abstract][Full Text] [Related]
36. Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model: A Pilot Study.
Stauch CM; Ammerman B; Sepulveda D; Aynardi MC; Garner MR; Lewis G; Morgan D; Dhawan A
Am J Sports Med; 2021 Jul; 49(9):2522-2527. PubMed ID: 34097540
[TBL] [Abstract][Full Text] [Related]
37. Behavioral Effects of Vaporized Delta-8 Tetrahydrocannabinol, Cannabidiol, and Mixtures in Male Rats.
Durbin DJ; King JM; Stairs DJ
Cannabis Cannabinoid Res; 2024 Apr; 9(2):601-611. PubMed ID: 36802211
[No Abstract] [Full Text] [Related]
38. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
Järbe TU; Henriksson BG; Ohlin GC
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.
Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
Neuropharmacology; 2004 Dec; 47(8):1170-9. PubMed ID: 15567426
[TBL] [Abstract][Full Text] [Related]
40. Female but not male rats show biphasic effects of low doses of Δ
Salviato BZ; Raymundi AM; Rodrigues da Silva T; Salemme BW; Batista Sohn JM; Araújo FS; Guimarães FS; Bertoglio LJ; Stern CA
Neuropharmacology; 2021 Sep; 196():108684. PubMed ID: 34181978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]